Melevodopa
Melevodopa (brand name Levomet) is a dopaminergic agent. It is the methyl ester of levodopa. It is used in tablet form as an effervescent prodrug with 250 times the water solubility of tablet levodopa.[1]
![]() | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C10H13NO4 |
| Molar mass | 211.217 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
See also
- Etilevodopa
References
- Hickey P, Stacy M (2011). "Available and emerging treatments for Parkinson's disease: a review". Drug Design, Development and Therapy. 5: 241–54. doi:10.2147/DDDT.S11836. PMC 3096539. PMID 21607020.
Antiparkinson agents (N04) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dopaminergics |
| ||||||||||
| Anticholinergics |
| ||||||||||
| Others | |||||||||||
| |||||||||||
| D1-like |
| ||||||
|---|---|---|---|---|---|---|---|
| D2-like | |||||||
| |||||||
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
